Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
21918574
TITLE
Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.
ABSTRACT
DATE PUBLISHED
2012 Jan
HISTORY
PUBSTATUS PUBSTATUSDATE
aheadofprint 2011/09/15
entrez 2011/09/16 06:00
pubmed 2011/09/16 06:00
medline 2012/04/13 06:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Rao F Rao Fangwen F Department of Medicine, University of California, San Diego, CA, USA.
Chiron S Chiron Stephane S
Wei Z Wei Zhiyun Z
Fung MM Fung Maple M MM
Chen Y Chen Yuqing Y
Wen G Wen Gen G
Khandrika S Khandrika Srikrishna S
Ziegler MG Ziegler Michael G MG
Benyamin B Benyamin Beben B
Montgomery G Montgomery Grant G
Whitfield JB Whitfield John B JB
Martin NG Martin Nicholas G NG
Waalen J Waalen Jill J
Hamilton BA Hamilton Bruce A BA
Mahata SK Mahata Sushil K SK
O'Connor DT O'Connor Daniel T DT
INVESTIGATORS
JOURNAL
MEDLINE JOURNAL
MEDLINETA: Am J Hypertens
COUNTRY: United States
ISSNLINKING: 0895-7061
NLMUNIQUEID: 8803676
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Twin Study
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites J Clin Invest. 1994 Jul;94(1):118-29 8040254
Cites J Clin Invest. 1995 Jul;96(1):568-78 7615829
Cites N Engl J Med. 1996 Feb 8;334(6):374-81 8538710
Cites Clin Chem. 1996 Jun;42(6 Pt 1):942-6 8665687
Cites J Comput Biol. 1994 Fall;1(3):191-8 8790464
Cites Nutr Rev. 1997 Mar;55(3):85-8 9170895
Cites Journ Annu Diabetol Hotel Dieu. 1997;:131-48 9296969
Cites Am J Cardiol. 1997 Aug 1;80(3):323-30 9264426
Cites Am J Physiol. 1997 Aug;273(2 Pt 1):E448-52 9277400
Cites J Clin Invest. 1997 Sep 1;100(5):1180-92 9276735
Cites J Clin Endocrinol Metab. 1997 Sep;82(9):2849-55 9284709
Cites Hypertension. 1997 Sep;30(3 Pt 2):619-23 9322991
Cites Eur J Endocrinol. 1997 Dec;137(6):655-8 9437232
Cites Hypertension. 1998 Jan;31(1 Pt 2):409-14 9453337
Cites J Clin Invest. 1998 Feb 15;101(4):863-76 9466982
Cites Am J Hum Genet. 1998 May;62(5):1198-211 9545414
Cites Diabetes. 1999 Sep;48(9):1787-93 10480609
Cites Physiol Genomics. 2004 Nov 17;19(3):277-91 15367723
Cites Cell. 2004 Dec 29;119(7):1041-54 15620361
Cites Am J Physiol Regul Integr Comp Physiol. 2005 May;288(5):R1411-6 15604304
Cites BMC Bioinformatics. 2005;6:79 15799782
Cites Hum Mol Genet. 2005 Jun 1;14(11):1529-38 15843401
Cites J Clin Invest. 2005 Jul;115(7):1942-52 16007257
Cites Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1275-82 16778068
Cites J Hypertens. 2007 Feb;25(2):329-43 17211240
Cites J Neurochem. 2007 Mar;100(6):1688-702 17348866
Cites Kidney Int. 2008 Jul;74(1):115-25 18432188
Cites Circulation. 2008 Jul 15;118(3):247-57 18591442
Cites Hypertension. 2009 Mar;53(3):473-9 19204185
Cites J Biol Chem. 2009 Oct 16;284(42):28498-509 19706599
Cites Am J Hypertens. 2010 Mar;23(3):327-33 20019673
Cites Hypertension. 2010 Apr;55(4):862-8 20194306
Cites Hum Mol Genet. 2010 Jul 1;19(13):2567-80 20378607
Cites Am J Hypertens. 2010 Aug;23(8):814; author reply 815 20644526
Cites Clin Endocrinol (Oxf). 2010 Aug;73(2):201-5 20148909
Cites Hypertension. 2010 Oct;56(4):623-8 20713919
Cites Hypertension. 1999 Nov;34(5):1152-62 10567198
Cites Stat Med. 2000 May 15;19(9):1217-35 10797518
Cites Annu Rev Physiol. 2000;62:413-37 10845097
Cites Biochem J. 2001 Jan 15;353(Pt 2):193-8 11139380
Cites Int J Obes Relat Metab Disord. 2001 Jan;25(1):132-7 11244469
Cites Am J Hypertens. 2001 Jun;14(6 Pt 2):103S-115S 11411745
Cites Cell. 2001 Aug 24;106(4):499-509 11525735
Cites J Neuroendocrinol. 2001 Oct;13(10):913-21 11679060
Cites Obes Res. 2002 Jan;10(1):14-21 11786597
Cites Hypertension. 2002 Feb;39(2 Pt 2):496-501 11882597
Cites Nat Rev Genet. 2002 Nov;3(11):872-82 12415317
Cites Twin Res. 2002 Oct;5(5):460-7 12537877
Cites N Engl J Med. 2003 Mar 20;348(12):1134-49 12646671
Cites Am J Hum Genet. 2004 Feb;74(2):197-207 14740315
Cites Nat Rev Genet. 2004 Apr;5(4):276-87 15131651
Cites Diabetes Care. 2004 Jun;27(6):1487-95 15161807
Cites Hypertension. 1990 Mar;15(3):237-46 2406199
Cites Life Sci. 1990;47(23):2143-53 2266783
Cites J Biol Chem. 1992 Feb 15;267(5):3066-73 1737762
Cites Neuroscience. 1992 Aug;49(3):497-528 1501763
Cites Cell. 1992 Oct 2;71(1):169-80 1394429
GRANTS
GRANTID AGENCY COUNTRY
KL2 TR000099 NCATS NIH HHS United States
MD000220 NIMHD NIH HHS United States
P01 HL058120 NHLBI NIH HHS United States
P60 MD000220 NIMHD NIH HHS United States
R01 DK094894 NIDDK NIH HHS United States
RR00827 NCRR NIH HHS United States
GENERAL NOTE
KEYWORDS
MESH HEADINGS
DESCRIPTORNAME QUALIFIERNAME
Adult
Aged
Aged, 80 and over
Body Mass Index
C-Reactive Protein genetics
Chromaffin Cells metabolism
Chromogranin A genetics
Female genetics
Genetic Pleiotropy genetics
Humans genetics
Leptin genetics
Male genetics
Metabolic Syndrome X genetics
Middle Aged genetics
Polymorphism, Genetic genetics
Promoter Regions, Genetic genetics
Risk genetics
Twins, Dizygotic genetics
Twins, Monozygotic genetics
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
REGISTRYNUMBER NAMEOFSUBSTANCE
0 CHGA protein, human
0 Chromogranin A
0 Leptin
9007-41-4 C-Reactive Protein
OTHER ID's
OTHERID SOURCE
NIHMS455832 NLM
PMC3664223 NLM